Cong Fang, Shijian Luo and Jingzhao Pan 的作品 RareMe 移动应用程序

设计师 Cong Fang, Shijian Luo and Jingzhao Pan 的作品 RareMe 移动应用程序荣获了极具声望的 2021 A' Design Award 铜奖，竞赛类别为移动技术、应用与软件设计。

铜移动· 2021

RareMe 移动应用程序

设计师： Cong Fang, Shijian Luo and Jingzhao Pan

客户: Zhejiang University

移动类别A' Design Award 铜奖获奖者

16,439

已验证的获奖者

验证 #111937 的获奖状态

在A' Design Award上查看新闻稿获奖徽章

色彩

设计作品

关于 RareMe 移动应用程序

RareMe是一款专为罕见病患者群体打造的移动应用程序。RareMe将患者及其家人与医院、医疗机构、药房、医生以及药物研发者连接起来。用户在注册时可选择患者、家属或医疗服务提供者的身份。患者可以撰写治疗日记,搜索全球范围内的药物与治疗方案,并通过推荐算法找到病情相似的其他用户。该应用程序已在iOS和Android平台上线,旨在让罕见病患者获得平等的关注与关怀。

荣誉认可

关于A' Design Award 铜奖

RareMe 移动应用程序是 A' Design Award 铜奖得主，这是授予以创造力、独创性和敏锐见长的杰出设计的极具声望的认可。铜奖得主是技艺娴熟、创意惊人的作品，印证了其设计师丰富的经验、想象力与机智。预计RareMe 移动应用程序将成为一件备受推崇、令人钦佩且被珍爱的物品，兼具显著的专业性与创新性。这件赢得 A' Design Award 铜奖的设计融入艺术、科学、设计和技术领域的最佳实践，并因注重细节而出类拔萃。RareMe 移动应用程序出色地满足需求，触动渴望，迷住情感，并吸引好奇心。

设计幕后

媒体资料包

由设计师提供的致谢、团队成员及技术详情。

独特属性: Rare diseases are currently affecting about 300 million patients worldwide. Due to their rare conditions, they cannot get the same degree of treatment and assistance as normal patients, especially in some developing countries. RareMe helps rare diseases patients with their recovery and therapy. By connecting with global medical research, institutions, hospitals, doctors, and drug developers, they can receive equal attention and care.
尺寸与包装: Launched on IOS and Android
标签: Rare Disease, app, patients, crowd-funding, mutual aid
生产技术: RareMe is an APP,which connects patients and their families with health-care providers, such as hospitals, medical institutions, pharmacies, doctors, drug developers, pharmaceuticals companies, etc. It also links rare disease patients with similar conditions with medical workers through intelligent recommendation algorithm, so as to make them feel not alone.
设计挑战: RareMe connects patients and their families with health-care providers, such as hospitals, medical institutions, pharmacies, doctors, drug developers, pharmaceuticals companies, etc.

The biggest problem is to contact all stakeholders, promote app through hospitals, medical institutions, and major media platforms, so that patients scattered around the world can know and join RareMe. With the help of a large number of patients gathering to solve the problem of drug research and distribution by low-cost crowdfunding.
研究: Rare diseases are currently affecting 3.5% - 5.9% of the worldwide population. There are more than 7,000 rare diseases known in the world, however, only less than 10% of the diseases have approved treatment drugs or programs.

Based on this huge social problem, we have conducted extensive interviews with medical professors of Harvard University and Medical Laboratory of Zhejiang University, and are eager to connect rare disease patients around the world in a simple and portable way. We have connected many medical workers and patients via the development of RareMe. In order to improve this current condition, we will add in more and more health-care providers in the future.
灵感: Rare diseases are lately affecting 3.5% - 5.9% of the worldwide population. More than 7,000 rare diseases are known, however, only less than 10% have approved treatment cures or programs. Due to the patients’ rare conditions, they’re not able to get the same degree of care and assistance as normal patients. Moreover, proper medicines and treatments are not available in some developing countries. They have few wardmates to communicate with, either.
项目周期: This project started in September 2019 in Hangzhou, China, and it is still under developing.
操作流程: At the beginning of registration, user will choose their own role as patients/family members or health-care providers, then enter the home page. Patients can write disease fighting diaries, seek for other users who have similar syndromes and fight together. They can also seek drugs and treatments around the world. As for health-care providers, they can contact patients quickly via RareMe and offer help.
团队成员: Cong Fang
Shijian Luo
Jingzhao Pan
Tianhe Zhang
Huan Lin
图片版权: The four images used in the app design are from the SHETU website(https://699pic.com/), and have been authorized. The authorization agreement is shown in the link
Link: https://pan.baidu.com/s/1-s5VTAN_XWqHc2ZyToIegQ
Password：70bo